Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 6kWORD 23k
9 September 2015
Question for written answer E-012628-15
to the Commission
Rule 130
Ramon Tremosa i Balcells (ALDE)

 Subject:  Lack of authorisation in certain Member States of antibiotics to combat bacterial diseases
 Answer in writing 

Some Member States, and certain other countries in Europe and elsewhere, have authorised the use of certain antibiotics to combat bacterial diseases such as fire blight (Erwinia amylovora) in exceptional cases, and provided that guarantees are given as to human health. These antibiotics have proven to be effective in combating the spread of infestations and can thus help ensure the prosperity of farms and the future of rural areas.

However, certain Member States, such as Spain, are still to approve their use despite the fact that fire blight is ravaging a substantial portion of pome fruit orchards.

What is the Commission's view of the fact that some Member States choose to combat this pest head-on while others have not authorised all of the means the EU has put at their disposal to eradicate fire blight and curb its spread.

Original language of question: ES 
Legal notice